What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Tris (hydroxymethyl) Aminomethane Market Size, Share, Growth and Industry analysis, By Type (Industrial Grade, Standard Grade, Ultra Pure Grade), By Application (Biological Buffer, Pharmaceutical Intermediates, Others) and Regional Forecast to 2034
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
TRIS (HYDROXYMETHYL) AMINOMETHANE MARKET OVERVIEW
The global tris (hydroxymethyl) aminomethane market size was valued at USD 0.727 billion in 2025 and is expected to reach USD 5.8 billion by 2034, growing at a compound annual growth rate (CAGR) of about 25.97% from 2025 to 2034.
The United States Tris (hydroxymethyl) Aminomethane Market size is projected at USD 0.24113 Billion in 2025, the Europe Tris (hydroxymethyl) Aminomethane Market size is projected at USD 0.22035 Billion in 2025, and the China Tris (hydroxymethyl) Aminomethane Market size is projected at USD 0.15966 Billion in 2025.
Tris(hydroxymethyl)aminomethane, commonly abbreviated as Tris or THAM, is a chemical compound with the molecular formula C4H11NO3. It is a white, crystalline, water-soluble solid that is commonly used as a biological buffer. Tris is a tertiary amine with three hydroxymethyl groups (-CH2OH) attached to the nitrogen atom. The amine group (-NH2) is located at the end of an alkyl chain (-CH2-) that is attached to the nitrogen atom. The presence of these hydroxyl and amine groups allows Tris to act as a buffer, helping to maintain a stable pH in biological and biochemical systems. Tris is commonly used as a buffer in biochemical and molecular biology applications, such as electrophoresis, DNA sequencing, and protein purification. It has a pKa value of 8.1, which means that it is an effective buffer in the pH range of 7.0 to 9.2.
Tris is also used in the formulation of various consumer products, such as shampoos and conditioners, and in the production of some pharmaceuticals. However, it is important to handle Tris with care, as it can be irritating to the eyes, skin, and respiratory system.
KEY FINDINGS
- Market Size and Growth: Valued at USD 0.727 billion in 2025, expected to reach USD 5.8 billion by 2034, growing at a CAGR 25.97%
- Key Market Driver: Approximately 42.5% of demand is driven by its use in buffer formulations across pharmaceutical and biochemical industries.
- Major Market Restraint: Nearly 28.7% of producers report raw material cost fluctuations as a significant limiting factor for production and pricing stability.
- Emerging Trends: Bio-based TRIS formulations have grown by 18.9%, highlighting a shift towards sustainable chemical manufacturing practices.
- Regional Leadership: Asia-Pacific contributes 39.6% of global demand, with rapid growth in pharmaceutical and academic research sectors.
- Competitive Landscape: Top five manufacturers control 57.2% of market share through vertical integration and proprietary purification technologies.
- Market Segmentation: Industrial grade holds 51.4%, standard grade 33.8%, and ultra-pure grade accounts for 14.8% of total market volume.
- Recent Development: Around 22.1% of companies expanded TRIS production capacity between 2023–2024 to meet rising biopharma demand.
COVID-19 IMPACT
The Disruption of the Supply Chain Had an Effect on Market Growth
The pandemic has disrupted supply chains and manufacturing operations, leading to shortages and delays in the production and distribution of Tris and other chemicals. This has resulted in increased prices for some chemicals, including Tris, and challenges for researchers and industries that rely on these chemicals for their work. In addition, the COVID-19 pandemic has increased demand for Tris and other biochemical reagents and buffers that are used in research related to the virus. This has created additional challenges for researchers who are trying to obtain these chemicals for their studies, as well as for manufacturers who are trying to meet the increased demand.
Overall, the COVID-19 pandemic has had a significant impact on the availability and cost of Tris and other chemicals, which has affected research and industry operations in various ways.
LATEST TRENDS
Tris has been Widely Employed as a Buffer in Numerous Biochemical Applications to Promote Market Expansion
Tris has been widely used as a buffer in various biological and biochemical applications, including electrophoresis, protein purification, and molecular biology techniques such as PCR and DNA sequencing. As a result, the demand for Tris has been steady over the years, and it is considered a staple chemical in many research laboratories and industries. There has been a growing interest in the development of new buffer systems that offer improved performance over traditional buffers such as Tris.
- TRIS buffer is used in 100% of Pfizer–BioNTech COVID-19 vaccine vials for ages 5–11, highlighting its regulatory acceptance in pediatric applications
- In a recent oral thin-film vaccine study, TRIS concentration was increased from 4 mM to 60 mM (a 1,400% rise) to enhance thermal stability
TRIS (HYDROXYMETHYL) AMINOMETHANE MARKET SEGMENTATION
By Type Analysis
By type, the tris (hydroxymethyl) aminomethane market is segmented into industrial grade, standard grade, and ultra-pure grade.
The industrial grade segment will dominate the tris (hydroxymethyl) aminomethane market in the coming years.
By Application Analysis
Based on applications, the tris (hydroxymethyl) aminomethane markets are biological buffer, pharmaceutical intermediates, and others.
The biological buffer use segment will lead the global share through forecast period.
DRIVING FACTORS
pH Stability and Biocompatibility will Accelerate Market Expansion
Tris has a pKa value of 8.1, which makes it an effective buffer in the pH range of 7.0 to 9.2. This makes Tris a popular choice for many biological and biochemical applications that require a stable pH environment. Tris is relatively non-toxic and biocompatible, making it an ideal buffer for use in many biological and biomedical applications, such as protein purification, DNA sequencing, and cell culture.
- Global chemical output rose by 6.1% in Jan–July 2024, underpinning higher demand for laboratory buffers like TRIS.
- The American Chemistry Council projects a 3.4% increase in global chemical production for 2024, supporting sustained TRIS consumption.
Molecular Biology Techniques to Support Market Demand
Tris is a versatile buffer that can be used in a wide range of applications. It is commonly used in electrophoresis, PCR, and other molecular biology techniques. Tris is readily available from many suppliers and is relatively inexpensive compared to other biological buffers. Tris has been used as a biological buffer for many years and has a well-established track record of use in research and industry. This has led to widespread adoption and acceptance of Tris as a reliable and effective buffer.
RESTRAINING FACTORS
The pH Limits and Interference with Some Assays will Limit Market Expansion
Although Tris is an effective buffer in the pH range of 7.0 to 9.2, it may not be suitable for applications that require a different pH range. For example, some enzymatic reactions require a pH outside of this range and may require a different buffer system. Tris may interfere with some biochemical assays, such as enzyme-linked immunosorbent assays (ELISAs), due to its inherent absorbance properties. In these cases, alternative buffers may be required.
- EU 27 chemical production dropped by 8.5% in 2023 versus 2022, tightening regional TRIS supply chains.
- 44% of chemical companies reported cuts to green capital expenditure in 2023–2024, limiting capacity upgrades for buffer manufacturing.
-
Request a Free sample to learn more about this report
TRIS (HYDROXYMETHYL) AMINOMETHANE MARKET REGIONAL INSIGHTS
North American to Grow at the Highest Tris (Hydroxymethyl) Aminomethane Market Share During the Forecast Period
North America is the dominating market for tris (hydroxymethyl) aminomethane, with being the largest consumer due to the presence of a large number of biotechnology and pharmaceutical companies, academic and research institutions. Tris is commonly used in these industries for various applications such as protein purification, electrophoresis, and PCR. Additionally, the growing research and development activities in the region are expected to boost the demand for tris (hydroxymethyl) aminomethane market in the coming years.
The Asia Pacific region is expected to witness significant growth in the demand for tris (hydroxymethyl) aminomethane due to the increasing investment in the biotech and pharmaceutical industries, the growing research and development activities, and the rising demand for high-quality healthcare products. Moreover, the increasing awareness about the benefits of Tris in various biological and biochemical applications is also expected to boost its demand in the region.
KEY INDUSTRY PLAYERS
Key Players Focus on Partnerships to Gain a Competitive Advantage
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.
- Changzhou Welton Chemical: Operates within China’s 44% share of global chemical output, reflecting strong domestic TRIS capacity.
- Tokyo Chemical Industry: Contributes to Japan’s 5.6% share of global chemicals value-added output, including TRIS reagents.
List of Top Tris (hydroxymethyl) Aminomethane Companies
- Changzhou Welton Chemical
- Tokyo Chemical Industry
- Hubei New De Sheng Material Science and Technology
- Hunan Yunbang Bio-pharmaceutical
- Biosynth Carbosynth
- Anhui Meisenbao Chemical
- Nanjing Search Biotech
- Merck
- Guangdong Guanghua Sci-Tech
- ITW Reagents
- Suzhou Yacoo Science
- Apollo Scientific
- Jiangsu Tianjiayi Chemical
- Nacalai Tesque
- Beyotime Biotechnology
- Ranjeck Technology
- Shangqiu Tengfei Biotechnology
- Yeasen Biotechnology
- ANGUS Chemical
REPORT COVERAGE
The market research study examines the worldwide market in detail, focusing on important elements such as leading players, product/services, or type, and leading end-use applications. Aside from that, the research analyses major advancements and provides insights into lighting market trends. In addition to the causes indicated above, the paper includes several other factors that have contributed to recent tris (hydroxymethyl) aminomethane market growth in some regions.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.72 Billion in 2025 |
Market Size Value By |
US$ 5.8 Billion by 2034 |
Growth Rate |
CAGR of 25.97% from 2025 to 2034 |
Forecast Period |
2025-2034 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The Tris (hydroxymethyl) Aminomethane Market is expected to touch USD 5.8 billion by 2034.
The Tris (hydroxymethyl) Aminomethane Market is expected to exhibit a CAGR of 25.97% over 2034.
Tris has been widely employed as a buffer in numerous biochemical applications are the driving factors of the Tris (hydroxymethyl) Aminomethane Market.
North America is the leading region for the tris (hydroxymethyl) aminomethane market.
Changzhou Welton Chemical, Tokyo Chemical Industry, Hubei New De Sheng Material Science and Technology, Hunan Yunbang Bio-pharmaceutical, Biosynth Carbosynth, Anhui Meisenbao Chemical, Nanjing Search Biotech, Merck, Guangdong Guanghua Sci-Tech, ITW Reagents, Suzhou Yacoo Science, Apollo Scientific, Jiangsu Tianjiayi Chemical, Nacalai Tesque, Beyotime Biotechnology, Ranjeck Technology, Shangqiu Tengfei Biotechnology, Yeasen Biotechnology, ANGUS Chemical are some of the key market players in the tris (hydroxymethyl) aminomethane market.
The Tris (hydroxymethyl) Aminomethane Market is expected to be valued at 0.727 billion USD in 2025.